GOLDAN KEITH A. (Chief Financial Officer) reported 1 transaction at SYNDAX PHARMACEUTICALS INC
Review the transaction codes below to understand the nature of each event.
Filed: 8/7/2025ACC: 0000950170-25-105258
Officer· Chief Financial Officer
Since Jun 2022
+1.23K
Net shares
Net buyer
$10.3K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
1.23K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1.23K
Price / share
$8.43
Trade value
$10.34K
% of position
1.3%
7/31/2025
92.45K→93.68K
Total
Net shares
+1.23K
Net value
$10.34K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/31/2025 | J · J | +1.23K | $8.43 | $10.34K | 1.3% | 92.45K | 93.68K |
| Total | +1.23K | $10.34K | ||||||
Derivative Transactions0
No derivative transactions reported